Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

被引：24
作者：
Bansal, Amar D. [1 ]
Hill, Chloe E. [2 ]
Berns, Jeffrey S. [1 ]
机构：
[1] Univ Penn, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
SEMINARS IN DIALYSIS | 2015年 / 28卷 / 04期
关键词：
GRANULOMATOUS INTERSTITIAL NEPHRITIS; ANTIDIURETIC-HORMONE SECRETION; HIGH-FLUX HEMODIALYSIS; PROTEIN-BINDING; PERITONEAL-DIALYSIS; PHARMACOKINETICS; CARBAMAZEPINE; LAMOTRIGINE; TOPIRAMATE; GABAPENTIN;
D O I：
10.1111/sdi.12385
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Epilepsy is a disorder with an approximate worldwide prevalence of 1%. Due to complexities of metabolism, protein-binding, renal elimination, and other pharmacokinetic parameters, the dosing of antiepileptic drugs (AEDs) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD) deserves special attention. This is a review of the most commonly prescribed AEDs with special focus on their indication, pharmacokinetics, and unique considerations for use in patients with CKD and ESRD. A review of their renal toxicities is also included.
引用
收藏
页码：404 / 412
页数：9
相关论文
共 50 条
  • [41] Perioperative Pharmacologic Management of Patients with End Stage Renal Disease
    Karambelkar, Ameet
    Kasekar, Riyaj
    Palevsky, Paul M.
    SEMINARS IN DIALYSIS, 2015, 28 (04) : 392 - 396
  • [42] Influenza vaccination in patients with end-stage renal disease
    Principi, Nicola
    Esposito, Susanna
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1249 - 1258
  • [43] Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis
    Pisano, Anna
    Zoccali, Carmine
    Bolignano, Davide
    D'Arrigo, Graziella
    Mallamaci, Francesca
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [44] Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival
    Abbott, KC
    Agodoa, LY
    CLINICAL NEPHROLOGY, 2002, 57 (03) : 208 - 214
  • [45] Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation
    Hu, Austin
    Niu, Jingbo
    Winkelmayer, Wolfgang C.
    SEMINARS IN NEPHROLOGY, 2018, 38 (06) : 618 - 628
  • [46] Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis
    Bologa, R.
    Levine, D.
    Parker, T.
    Gordon, B.
    Lanto, A.
    Cheigh, J.
    Stenzel, K.
    Rubin, A.
    CLINICAL NEPHROLOGY, 2009, 72 (06) : 437 - 441
  • [47] Mortality rate of end-stage kidney disease patients in Taiwan
    Wu, Bo-Sheng
    Wei, Chia-Ling Helen
    Yang, Chih-Yu
    Lin, Ming-Huang
    Hsu, Chih-Cheng
    Hsu, Yu-Juei
    Lin, Shih-Hua
    Tarng, Der-Cherng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 : S12 - S19
  • [48] Aciclovir/gabapentinEncephalopathy in patients with end-stage renal disease: 2 case reports
    Reactions Weekly, 2010, 1286 (1) : 7 - 7
  • [49] Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease
    Dekel, Boaz Gedaliahu Samolsky
    Donati, Gabriele
    Vasarri, Alessio
    Chiocchini, Anna Laura Croci
    Gori, Alberto
    Cavallari, Giuseppe
    Di Nino, Gianfranco
    Mercolini, Laura
    Protti, Michele
    Mandrioli, Roberto
    Melotti, Rita Maria
    La Manna, Gaetano
    PAIN PRACTICE, 2017, 17 (05) : 604 - 615
  • [50] Optimizing Oncological Care in Patients with End-Stage Chronic Kidney Disease on Dialysis: Indian Scenario
    Sreenath, Nihanthy D.
    Kushwaha, Naveen Kumar
    Kaushik, M. R.
    Govind, Rajath
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2025,
12345